Regarding the relationship between LRFN2 and cancer, LRFN2 is known to inhibit esophageal cancer progression via the regulation of the Wnt/β-catenin and NF-κB signaling pathways [23]. This evidence concerns the gene LRFN2 and esophageal cancer.